SAEM Final Exam Prep Document | 2026/2027 Edition | 250
Verified Questions
SAEM Final Exam 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100% Verified Solutions |
Updated Per Latest Guidelines | Graded A+
This comprehensive test bank contains 250 verified questions and detailed answers designed to prepare
students for the SAEM (Society for Academic Emergency Medicine) final exam. Covering core topics
in emergency medicine, the questions reflect the latest clinical guidelines and exam blueprints. Each
answer includes rationales and distractor explanations to reinforce learning. Ideal for self-assessment
and mastery of emergency medicine principles.
Abstract:
The SAEM Final Exam Prep Document for the 2026/2027 academic year provides a rigorous test bank of 250
verified questions covering all major domains of emergency medicine. Each question is accompanied by a detailed
answer with step-by-step rationales and explanations of incorrect options, facilitating deep understanding. The
content is aligned with the latest evidence-based guidelines from the American Heart Association, American
College of Surgeons, and other authoritative bodies. This resource is designed for medical students, residents, and
practitioners seeking to excel in the SAEM final exam. Emphasis is placed on high-yield topics such as
resuscitation, trauma, medical emergencies, and special populations. The document also includes updates on
emerging issues like pandemic response and telehealth in emergency care. With a focus on clinical reasoning and
application, this test bank serves as an essential tool for exam preparation and ongoing education.
Content Area Overview:
Content Area Questions Key Topics Weight
Resuscitation and Critical Care 1-50 Airway management, cardiac arrest, shock, 20%
sepsis, ACLS
Trauma and Injury Management 51-100 Blunt and penetrating trauma, head injury, 20%
spinal injury, burns
Medical Emergencies 101-160 Cardiac emergencies, respiratory failure, 24%
stroke, DKA, PE
Pediatric and Geriatric 161-200 Pediatric fever, dehydration, child abuse; 16%
Emergencies geriatric falls, polypharmacy
Toxicology and Environmental 201-230 Overdose, poisoning, envenomation, 12%
Emergencies hypothermia, heat illness
Miscellaneous (Ethics, 231-250 Informed consent, disaster management, 8%
Administration, Procedures) ultrasound, suturing
Page 1
,Q1. Which of the following best explains the paradoxical effect of naloxone in a patient with
opioid-induced respiratory depression who also has chronic pain on methadone maintenance
therapy?
A. Naloxone has a longer half-life than methadone, causing rebound respiratory depression.
B. Naloxone reverses analgesia, leading to increased sympathetic outflow and tachypnea.
C. Naloxone has higher affinity for mu-receptors but shorter duration of action, risking acute
withdrawal and return of respiratory depression.
D. Naloxone competitively antagonizes methadone at NMDA receptors, worsening pain and
hyperventilation.
Correct Answer: C. Naloxone has higher affinity for mu-receptors but shorter duration of action,
risking acute withdrawal and return of respiratory depression.
Rationale: Naloxone has a high affinity for mu-opioid receptors but a short half-life (30-80 min)
compared to methadone (24-36 h). In chronic methadone users, naloxone can precipitate acute
withdrawal while its effect wears off before methadone is cleared, leading to recurrent respiratory
depression. Option A is incorrect because naloxone's half-life is shorter, not longer. Option B is incorrect
because naloxone does not cause tachypnea via sympathetic activation; it reverses opioid effects. Option
D is incorrect because naloxone does not act on NMDA receptors.
Why Wrong:
A - Naloxone's half-life is shorter than methadone's, not longer.
B - Naloxone reverses opioid effects, including analgesia, but does not directly increase sympathetic
outflow to cause tachypnea.
D - Naloxone is a mu-receptor antagonist, not an NMDA receptor antagonist.
Reference: Tintinalli, J.E., et al. (2026). Emergency Medicine: A Comprehensive Study Guide, 9th Ed.,
Ch. 38, pp. 540-545.
Q2. A patient presents with severe hypertension (220/130 mm Hg), headache, and papilledema.
Which of the following antihypertensive agents is most appropriate for immediate blood pressure
reduction while minimizing the risk of cerebral hypoperfusion?
A. Sodium nitroprusside
B. Labetalol
C. Hydralazine
D. Nifedipine
Correct Answer: B. Labetalol
Rationale: Labetalol, a combined alpha- and beta-blocker, reduces blood pressure gradually and
predictably without causing reflex tachycardia or significant cerebral vasodilation, making it preferred in
hypertensive encephalopathy. Sodium nitroprusside (A) is potent but can cause cyanide toxicity and
increased intracranial pressure. Hydralazine (C) causes reflex tachycardia and unpredictable response.
Nifedipine (D) short-acting can cause precipitous drop in pressure leading to cerebral ischemia.
Why Wrong:
A - Nitroprusside may increase intracranial pressure and carries risk of cyanide toxicity.
C - Hydralazine causes reflex tachycardia and has unpredictable hypotensive effect.
D - Short-acting nifedipine can cause rapid, uncontrolled hypotension and cerebral hypoperfusion.
Reference: Chobanian, A.V., et al. (2003). JNC 7 Report. JAMA, 289(19):2560-2572. Updated in
ACC/AHA 2017 Guidelines.
Page 2
,Q3. A patient with suspected acute coronary syndrome has an ECG showing ST-segment depression
in leads V1-V4 and tall R waves in V1-V2. Which of the following is the most likely diagnosis?
A. Anterior ST-elevation myocardial infarction
B. Posterior myocardial infarction
C. Acute pericarditis
D. Left ventricular hypertrophy with strain
Correct Answer: B. Posterior myocardial infarction
Rationale: ST-segment depression in V1-V4, especially with tall R waves in V1-V2, is a classic pattern for
posterior MI, often due to occlusion of the left circumflex artery. Anterior STEMI (A) would show ST
elevation in V1-V4. Pericarditis (C) typically shows diffuse ST elevation with PR depression. LVH with
strain (D) shows asymmetric ST depression and T wave inversion, but not tall R waves in V1-V2.
Why Wrong:
A - Anterior STEMI presents with ST elevation in V1-V4, not depression.
C - Pericarditis shows diffuse ST elevation and PR depression, not isolated ST depression in
precordial leads.
D - LVH with strain shows ST depression and T inversion but not tall R waves in V1-V2.
Reference: O'Gara, P.T., et al. (2013). ACCF/AHA Guideline for STEMI. Circulation, 127(4):e362-e425.
Q4. A patient with a history of atrial fibrillation on warfarin presents with acute onset of severe
headache, nausea, and nuchal rigidity. CT head shows no hemorrhage. Lumbar puncture reveals
xanthochromia. Which of the following is the most appropriate next step in management?
A. Administer protamine sulfate and start heparin infusion
B. Administer vitamin K and fresh frozen plasma, then perform CT angiography
C. Start nicardipine infusion and obtain MRI brain
D. Give mannitol and initiate hyperventilation
Correct Answer: B. Administer vitamin K and fresh frozen plasma, then perform CT angiography
Rationale: The presentation suggests subarachnoid hemorrhage (SAH) despite negative CT. In a patient
on warfarin, reversal with vitamin K and FFP is urgent to prevent rebleeding, followed by CT
angiography to identify aneurysm. Protamine (A) reverses heparin, not warfarin. Nicardipine (C) is used
for vasospasm after aneurysm secured, not first step. Mannitol/hyperventilation (D) is for elevated ICP,
not specific to SAH with anticoagulation.
Why Wrong:
A - Protamine reverses heparin, not warfarin; warfarin reversal requires vitamin K and FFP.
C - Nicardipine is for vasospasm prophylaxis after aneurysm treatment, not initial management of
suspected SAH with coagulopathy.
D - Mannitol and hyperventilation are for elevated ICP, but do not address coagulopathy or need to
identify aneurysm source.
Reference: Connolly, E.S., et al. (2012). AHA/ASA Guidelines for SAH. Stroke, 43(6):1711-1737.
Page 3
, Q5. A patient presents with acute onset of severe abdominal pain, vomiting, and distension.
Abdominal X-ray shows a 'coffee bean' sign. Which of the following is the most appropriate initial
management?
A. Nasogastric decompression and urgent surgical consultation
B. Barium enema for diagnostic confirmation
C. CT abdomen with oral and IV contrast
D. Administration of neostigmine
Correct Answer: A. Nasogastric decompression and urgent surgical consultation
Rationale: The 'coffee bean' sign on X-ray is pathognomonic for sigmoid volvulus. Initial management
includes nasogastric decompression and urgent surgical consultation for possible endoscopic detorsion
or surgery. Barium enema (B) is contraindicated if perforation suspected and may delay definitive care.
CT (C) may be used but not before decompression. Neostigmine (D) is used for acute colonic
pseudo-obstruction (Ogilvie syndrome), not volvulus.
Why Wrong:
B - Barium enema is contraindicated if perforation is possible and may delay surgery.
C - CT may be helpful but initial management should prioritize decompression and surgical
evaluation.
D - Neostigmine is indicated for colonic pseudo-obstruction, not mechanical obstruction like
volvulus.
Reference: Bailey & Love's Short Practice of Surgery, 28th Ed., Ch. 67: Intestinal Obstruction.
Q6. A patient with diabetic ketoacidosis has an initial serum potassium of 5.5 mEq/L. After starting
insulin and fluids, the potassium level drops to 3.0 mEq/L. Which of the following best explains this
rapid decline?
A. Insulin stimulates Na+/K+ ATPase, shifting potassium into cells, and dilution from fluid
resuscitation
B. Insulin causes renal potassium wasting by increasing aldosterone secretion
C. Fluid resuscitation with normal saline causes potassium loss via diuresis
D. Bicarbonate administration during DKA treatment drives potassium into cells
Correct Answer: A. Insulin stimulates Na+/K+ ATPase, shifting potassium into cells, and dilution
from fluid resuscitation
Rationale: Insulin promotes cellular uptake of potassium via Na+/K+ ATPase, and the large volume of IV
fluids dilutes extracellular potassium. In DKA, total body potassium is depleted despite initial
hyperkalemia due to acidosis; as acidosis corrects, potassium shifts intracellularly. Option B is incorrect
because insulin does not increase aldosterone. Option C is partially true but dilution is a minor factor;
the main mechanism is insulin-mediated shift. Option D is incorrect because bicarbonate is not routinely
given in DKA unless severe acidosis; its use is controversial.
Why Wrong:
B - Insulin does not stimulate aldosterone; renal potassium loss is not the primary mechanism.
C - Dilution from fluids contributes but the major cause is insulin-induced potassium shift into cells.
D - Bicarbonate is not standard in DKA management; the decline occurs even without bicarbonate.
Reference: Kitabchi, A.E., et al. (2009). Hyperglycemic Crises in Diabetes. Diabetes Care,
32(7):1335-1343.
Page 4
Verified Questions
SAEM Final Exam 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100% Verified Solutions |
Updated Per Latest Guidelines | Graded A+
This comprehensive test bank contains 250 verified questions and detailed answers designed to prepare
students for the SAEM (Society for Academic Emergency Medicine) final exam. Covering core topics
in emergency medicine, the questions reflect the latest clinical guidelines and exam blueprints. Each
answer includes rationales and distractor explanations to reinforce learning. Ideal for self-assessment
and mastery of emergency medicine principles.
Abstract:
The SAEM Final Exam Prep Document for the 2026/2027 academic year provides a rigorous test bank of 250
verified questions covering all major domains of emergency medicine. Each question is accompanied by a detailed
answer with step-by-step rationales and explanations of incorrect options, facilitating deep understanding. The
content is aligned with the latest evidence-based guidelines from the American Heart Association, American
College of Surgeons, and other authoritative bodies. This resource is designed for medical students, residents, and
practitioners seeking to excel in the SAEM final exam. Emphasis is placed on high-yield topics such as
resuscitation, trauma, medical emergencies, and special populations. The document also includes updates on
emerging issues like pandemic response and telehealth in emergency care. With a focus on clinical reasoning and
application, this test bank serves as an essential tool for exam preparation and ongoing education.
Content Area Overview:
Content Area Questions Key Topics Weight
Resuscitation and Critical Care 1-50 Airway management, cardiac arrest, shock, 20%
sepsis, ACLS
Trauma and Injury Management 51-100 Blunt and penetrating trauma, head injury, 20%
spinal injury, burns
Medical Emergencies 101-160 Cardiac emergencies, respiratory failure, 24%
stroke, DKA, PE
Pediatric and Geriatric 161-200 Pediatric fever, dehydration, child abuse; 16%
Emergencies geriatric falls, polypharmacy
Toxicology and Environmental 201-230 Overdose, poisoning, envenomation, 12%
Emergencies hypothermia, heat illness
Miscellaneous (Ethics, 231-250 Informed consent, disaster management, 8%
Administration, Procedures) ultrasound, suturing
Page 1
,Q1. Which of the following best explains the paradoxical effect of naloxone in a patient with
opioid-induced respiratory depression who also has chronic pain on methadone maintenance
therapy?
A. Naloxone has a longer half-life than methadone, causing rebound respiratory depression.
B. Naloxone reverses analgesia, leading to increased sympathetic outflow and tachypnea.
C. Naloxone has higher affinity for mu-receptors but shorter duration of action, risking acute
withdrawal and return of respiratory depression.
D. Naloxone competitively antagonizes methadone at NMDA receptors, worsening pain and
hyperventilation.
Correct Answer: C. Naloxone has higher affinity for mu-receptors but shorter duration of action,
risking acute withdrawal and return of respiratory depression.
Rationale: Naloxone has a high affinity for mu-opioid receptors but a short half-life (30-80 min)
compared to methadone (24-36 h). In chronic methadone users, naloxone can precipitate acute
withdrawal while its effect wears off before methadone is cleared, leading to recurrent respiratory
depression. Option A is incorrect because naloxone's half-life is shorter, not longer. Option B is incorrect
because naloxone does not cause tachypnea via sympathetic activation; it reverses opioid effects. Option
D is incorrect because naloxone does not act on NMDA receptors.
Why Wrong:
A - Naloxone's half-life is shorter than methadone's, not longer.
B - Naloxone reverses opioid effects, including analgesia, but does not directly increase sympathetic
outflow to cause tachypnea.
D - Naloxone is a mu-receptor antagonist, not an NMDA receptor antagonist.
Reference: Tintinalli, J.E., et al. (2026). Emergency Medicine: A Comprehensive Study Guide, 9th Ed.,
Ch. 38, pp. 540-545.
Q2. A patient presents with severe hypertension (220/130 mm Hg), headache, and papilledema.
Which of the following antihypertensive agents is most appropriate for immediate blood pressure
reduction while minimizing the risk of cerebral hypoperfusion?
A. Sodium nitroprusside
B. Labetalol
C. Hydralazine
D. Nifedipine
Correct Answer: B. Labetalol
Rationale: Labetalol, a combined alpha- and beta-blocker, reduces blood pressure gradually and
predictably without causing reflex tachycardia or significant cerebral vasodilation, making it preferred in
hypertensive encephalopathy. Sodium nitroprusside (A) is potent but can cause cyanide toxicity and
increased intracranial pressure. Hydralazine (C) causes reflex tachycardia and unpredictable response.
Nifedipine (D) short-acting can cause precipitous drop in pressure leading to cerebral ischemia.
Why Wrong:
A - Nitroprusside may increase intracranial pressure and carries risk of cyanide toxicity.
C - Hydralazine causes reflex tachycardia and has unpredictable hypotensive effect.
D - Short-acting nifedipine can cause rapid, uncontrolled hypotension and cerebral hypoperfusion.
Reference: Chobanian, A.V., et al. (2003). JNC 7 Report. JAMA, 289(19):2560-2572. Updated in
ACC/AHA 2017 Guidelines.
Page 2
,Q3. A patient with suspected acute coronary syndrome has an ECG showing ST-segment depression
in leads V1-V4 and tall R waves in V1-V2. Which of the following is the most likely diagnosis?
A. Anterior ST-elevation myocardial infarction
B. Posterior myocardial infarction
C. Acute pericarditis
D. Left ventricular hypertrophy with strain
Correct Answer: B. Posterior myocardial infarction
Rationale: ST-segment depression in V1-V4, especially with tall R waves in V1-V2, is a classic pattern for
posterior MI, often due to occlusion of the left circumflex artery. Anterior STEMI (A) would show ST
elevation in V1-V4. Pericarditis (C) typically shows diffuse ST elevation with PR depression. LVH with
strain (D) shows asymmetric ST depression and T wave inversion, but not tall R waves in V1-V2.
Why Wrong:
A - Anterior STEMI presents with ST elevation in V1-V4, not depression.
C - Pericarditis shows diffuse ST elevation and PR depression, not isolated ST depression in
precordial leads.
D - LVH with strain shows ST depression and T inversion but not tall R waves in V1-V2.
Reference: O'Gara, P.T., et al. (2013). ACCF/AHA Guideline for STEMI. Circulation, 127(4):e362-e425.
Q4. A patient with a history of atrial fibrillation on warfarin presents with acute onset of severe
headache, nausea, and nuchal rigidity. CT head shows no hemorrhage. Lumbar puncture reveals
xanthochromia. Which of the following is the most appropriate next step in management?
A. Administer protamine sulfate and start heparin infusion
B. Administer vitamin K and fresh frozen plasma, then perform CT angiography
C. Start nicardipine infusion and obtain MRI brain
D. Give mannitol and initiate hyperventilation
Correct Answer: B. Administer vitamin K and fresh frozen plasma, then perform CT angiography
Rationale: The presentation suggests subarachnoid hemorrhage (SAH) despite negative CT. In a patient
on warfarin, reversal with vitamin K and FFP is urgent to prevent rebleeding, followed by CT
angiography to identify aneurysm. Protamine (A) reverses heparin, not warfarin. Nicardipine (C) is used
for vasospasm after aneurysm secured, not first step. Mannitol/hyperventilation (D) is for elevated ICP,
not specific to SAH with anticoagulation.
Why Wrong:
A - Protamine reverses heparin, not warfarin; warfarin reversal requires vitamin K and FFP.
C - Nicardipine is for vasospasm prophylaxis after aneurysm treatment, not initial management of
suspected SAH with coagulopathy.
D - Mannitol and hyperventilation are for elevated ICP, but do not address coagulopathy or need to
identify aneurysm source.
Reference: Connolly, E.S., et al. (2012). AHA/ASA Guidelines for SAH. Stroke, 43(6):1711-1737.
Page 3
, Q5. A patient presents with acute onset of severe abdominal pain, vomiting, and distension.
Abdominal X-ray shows a 'coffee bean' sign. Which of the following is the most appropriate initial
management?
A. Nasogastric decompression and urgent surgical consultation
B. Barium enema for diagnostic confirmation
C. CT abdomen with oral and IV contrast
D. Administration of neostigmine
Correct Answer: A. Nasogastric decompression and urgent surgical consultation
Rationale: The 'coffee bean' sign on X-ray is pathognomonic for sigmoid volvulus. Initial management
includes nasogastric decompression and urgent surgical consultation for possible endoscopic detorsion
or surgery. Barium enema (B) is contraindicated if perforation suspected and may delay definitive care.
CT (C) may be used but not before decompression. Neostigmine (D) is used for acute colonic
pseudo-obstruction (Ogilvie syndrome), not volvulus.
Why Wrong:
B - Barium enema is contraindicated if perforation is possible and may delay surgery.
C - CT may be helpful but initial management should prioritize decompression and surgical
evaluation.
D - Neostigmine is indicated for colonic pseudo-obstruction, not mechanical obstruction like
volvulus.
Reference: Bailey & Love's Short Practice of Surgery, 28th Ed., Ch. 67: Intestinal Obstruction.
Q6. A patient with diabetic ketoacidosis has an initial serum potassium of 5.5 mEq/L. After starting
insulin and fluids, the potassium level drops to 3.0 mEq/L. Which of the following best explains this
rapid decline?
A. Insulin stimulates Na+/K+ ATPase, shifting potassium into cells, and dilution from fluid
resuscitation
B. Insulin causes renal potassium wasting by increasing aldosterone secretion
C. Fluid resuscitation with normal saline causes potassium loss via diuresis
D. Bicarbonate administration during DKA treatment drives potassium into cells
Correct Answer: A. Insulin stimulates Na+/K+ ATPase, shifting potassium into cells, and dilution
from fluid resuscitation
Rationale: Insulin promotes cellular uptake of potassium via Na+/K+ ATPase, and the large volume of IV
fluids dilutes extracellular potassium. In DKA, total body potassium is depleted despite initial
hyperkalemia due to acidosis; as acidosis corrects, potassium shifts intracellularly. Option B is incorrect
because insulin does not increase aldosterone. Option C is partially true but dilution is a minor factor;
the main mechanism is insulin-mediated shift. Option D is incorrect because bicarbonate is not routinely
given in DKA unless severe acidosis; its use is controversial.
Why Wrong:
B - Insulin does not stimulate aldosterone; renal potassium loss is not the primary mechanism.
C - Dilution from fluids contributes but the major cause is insulin-induced potassium shift into cells.
D - Bicarbonate is not standard in DKA management; the decline occurs even without bicarbonate.
Reference: Kitabchi, A.E., et al. (2009). Hyperglycemic Crises in Diabetes. Diabetes Care,
32(7):1335-1343.
Page 4
